Several recent studies have identified inflammatory mediators, such as IL-1, IL-6, and Tumor Necrosis Factor (TNF)-α, as contributing to the development of sarcopenia [37], since they may induce muscle atrophy promoting protein degradation and reactive oxygen species (ROS) accumulation [38,39]. This evidence concerns the gene IL6 and sarcopenia.